Tumor-Infiltrating Basophils Are Associated With Improved Prognosis in Colorectal Cancer

Read full text
Authors: Oskari Rahkola, Henna Karjalainen, Ville K. Äijälä, Meeri Kastinen, Vilja V. Tapiainen, Hanna Elomaa, Onni Sirkiä, Vesa‐Matti Pohjanen, Maarit Ahtiainen, Olli Helminen, Taneli T. Mattila, Outi Lindgren
+12 more Erkki‐Ville Wirta, Jukka Rintala, Sanna Meriläinen, Juha Saarnio, Tero Rautio, Toni T. Seppälä, Jan Böhm, Jukka‐Pekka Mecklin, Anne Tuomisto, Markus J. Mäkinen, Juha P. Väyrynen, Päivi Sirniö
Cited by: 1
References: 46

Abstract

Purpose Basophils are rare granulocytic cells known for their role in allergic reactions, but they may also be involved in other diseases such as cancer. However, the role of tumor-infiltrating basophils in colorectal cancer (CRC) remains unexplored. Here, we aimed to clarify the significance of basophils in CRC by analyzing tumor tissue from two CRC cohorts (N=1,830) and blood samples from 730 patients. Materials and Methods Tumor-infiltrating basophils were identified and quantified using double immunohistochemistry (proMBP1 for basophils, cytokeratin for tumor cells) combined with digital image analysis, and blood basophil counts were measured. The associations between basophils (in tumor tissue and blood) and clinicopathological features, prognosis, immune cell profiles, and systemic inflammation markers were examined. Results Higher densities of tumor-infiltrating basophils showed an inverse association with cancer-specific mortality, with stronger evidence in Cohort 2 than in Cohort 1. After adjusting for key prognostic factors (including disease stage and mismatch repair status), the HR for cancer-specific mortality comparing high vs. low basophil density was 0.67 (95%CI 0.43-1.03, p Trend =0.051) in Cohort 1 (N=749), and 0.54 (95%CI 0.40-0.74, p Trend

Fields of Study & Subjects

Mast cells and histamine Coagulation Bradykinin Polyphosphates and Angioedema Cancer Stress Anesthesia and Immune Response

Publication details

Journal / source
Laboratory Investigation
Publisher
Elsevier BV
Volume
106
Issue
9
Pages
106152–106152
Publication date
9 July 2026
Language
EN